Such trials should compare outcomes of standard lifestyle intervention versus phenotype-tailored interventions, with the latter emphasizing resistance training and protein supplementation for low muscle mass obesity, intensive dietary modification for those with predominant dyslipidemia, and insulin-sensitizing interventions for those with predominant HOMA-IR elevation. This evidence concerns the gene INS and obesity disorder.